FREE SHIPPING ON ORDERS OVER $150

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

$22.19

Quantity
- +
Description

A public comment period is open through June 29, 2026

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

Direct-to-consumer prescription companies like Hims & Hers (public) and Ro (Series E) have expanded their offerings to include GLP-1s amidst rising popularity of the drugs

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

Safety & Medical History: GLP-1 Agonist is FDA-approved and considered safe for eligible patients under medical supervision

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

If youre having side effects, your dose is too high. This delayed gastric emptying may lead to reduced efficacy of birth-control pills by reducing their absorption, though the research on this is still unclear

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

Hyponatremia (low sodium) can cause confusion, headache, seizures, and in severe cases, cerebral edema

blue cross glp 1 A handful of nonprofit and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs. Then they quickly pulled them back out. It's still early days of BCBSM pulling back on GLP-1

You may also like

recommand products